WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.

Quotes for WntResearch AB

Right Now

+/-
-0.095
%
-7,92%
Latest
1.105
High
1.15
Low
1.06
Volume
945 934
Turnover (SEK)
1 030 562
Value (MSEK)
69,2

Board

CEO

  • Anders Rabbe (tf)

Chairman Of The Board

  • Gudrun Anstrén

Board

  • Janna Sand-Dejmek
  • Martin Olovsson
  • Peter Ström
  • Tommy Andersson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 12,21 12,21 2020-12-31
Nordnet Pensionsförsäkring 6,47 6,47 2020-12-31
Kjell Stenberg 3,03 3,03 2020-12-31
Tommy Andersson 2,06 2,06 2021-02-16
Linfan Zhang 1,99 1,99 2020-12-31
Gunvald Berger 1,52 1,52 2020-12-31
Lars-Erik Forsgårdh 1,33 1,33 2020-12-31
Thomas Mellqvist 0,76 0,76 2020-12-31
Robert Joki 0,66 0,66 2020-12-31
Nils Qvarner 0,62 0,62 2020-12-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2021-03-10 Extra bolagsstämma 2021

  • 2021-05-06 Årsstämma 2020

  • 2021-05-06 Delårsrapport 2021-Q1

  • 2021-08-19 Delårsrapport 2021-Q2

  • 2021-11-18 Delårsrapport 2021-Q3

  • 2022-02-24 Bokslutskommuniké 2021